sultopride
This page covers all sultopride drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(2) dopamine receptor, D(3) dopamine receptor.
Targets
D(2) dopamine receptor, D(3) dopamine receptor
Phase 2 pipeline (1)
- Barnetil · Neuroscience
Barnetil works by blocking the D(2) dopamine receptor, which helps regulate mood and emotional responses.
Patent intelligence
- sultopride patent landscape — aggregated cliff calendar, attackable patents, originator estates